BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 77255)

  • 1. [Reply to W. L. Thompson's commentary (Infusionstherapie 4:56-62 1977) on G. Lindblad's and J. Falk's study on "Course of hydroxyethyl starch and dextran concentration in blood and liver of rabbits and the histopathological consequences of hydroxyethyl starch storage (Infusionstherapie 3:301-3 1976)].
    Infusionsther Klin Ernahr; 1978 Apr; 5(2):118-9. PubMed ID: 77255
    [No Abstract]   [Full Text] [Related]  

  • 2. [Determination of the plasma elimination of hydroxyethyl starch and dextran using improved analytical methods].
    Förster H; Wicarkzyk C; Dudziak R
    Infusionsther Klin Ernahr; 1981 Apr; 8(2):88-94. PubMed ID: 6164643
    [No Abstract]   [Full Text] [Related]  

  • 3. [Concerning the contribution by F. Jesch, G. Hübner, V. Zumtobel, M. Zimmermann and K. Messmer, hydroxyethyl starch (HAS 450/0,7) in plasma and liver--course of concentration and human histologic changes [Infusionstherapie 6:112-117 (1979)].
    Thompson WL
    Infusionsther Klin Ernahr; 1979 Aug; 6(4):262-3. PubMed ID: 90652
    [No Abstract]   [Full Text] [Related]  

  • 4. [Long term tolerance of highly dosed infusions of hydroxylethylstarch and dextran 60 in normovolemic rabbits].
    Hölscher B
    Infusionsther Klin Ernahr; 1975 Jun; 2(3):215-20. PubMed ID: 52620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravascular persistence of hydroxyethyl starch in man.
    Boon JC; Jesch F; Ring J; Messmer K
    Eur Surg Res; 1976; 8(6):497-503. PubMed ID: 65282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Intravascular persistence, tissue storage and excretion of hydroxyethyl starch (HAS)].
    Thompson WL; Fukushima T; Rutherford RB; Walton RP
    Infusionsther Klin Ernahr; 1979 Jun; 6(3):151-5. PubMed ID: 88413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effects of low molecular hydroxyethyl starch (HES) on the kidney -- a comparison with low molecular dextran].
    Yamasaki H
    Masui; 1975 Jun; 24(6):580-600. PubMed ID: 51106
    [No Abstract]   [Full Text] [Related]  

  • 8. [Blood volume replacement using hydroxyethyl starch or Dextran 60].
    Hölscher B
    Infusionstherapie (1973); 1974 Apr; 1(4):281-5. PubMed ID: 4142945
    [No Abstract]   [Full Text] [Related]  

  • 9. [Comparative investigations of hydroxyethyl starch and dextran 60 in Isovolaemic haemodilution and haemorrhagic shock of rats (author's transl)].
    Hölscher B; Edeling M; Fahrmeier G; Kagel S
    Anaesthesist; 1975 May; 24(5):215-8. PubMed ID: 56902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of physiological saline, dextran 70, hydroxyethyl starch, degraded gelatin, and fat emulsion solutions on screen filtration pressure.
    Elmér O; Göransson G; Saku M; Bengmark S
    Eur Surg Res; 1977; 9(2):85-95. PubMed ID: 67041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical comparison of plasma substitutes, dextran and hydroxyethyl starch].
    Hayashi K; Higashi H
    Masui; 1975 Sep; 24(9):853-9. PubMed ID: 53296
    [No Abstract]   [Full Text] [Related]  

  • 12. [Formation of high-molecular aggregates between serum amylase and colloidal plasma substitutes (author's transl)].
    Köhler H; Kirch W; Horstmann HJ
    Anaesthesist; 1977 Nov; 26(11):623-7. PubMed ID: 74216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Blood regeneration after blood substitution with dextran 60 or hydroxyethyl starch of an identical volume].
    Hölscher B; Kagel S
    Infusionsther Klin Ernahr; 1976 Aug; 3(4):250-3. PubMed ID: 60284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Anaphylactoid reaction in rats after administration of dextran and hydroxyethyl starch manufactured in Czechoslovakia (author's transl)].
    Skala E; Pospísil J; Tachecí O
    Cas Lek Cesk; 1980 Oct; 119(40-41):1098-100. PubMed ID: 6169436
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparable studies of the behaviour of the plasmic coagulation, the fibrinolysis as well as the platelets under application of dextran or hydroxyethyl-starch (HES).
    Popov-Cenić S; Müller N; Kladetzky RG; Hack G; Lang U
    Bibl Anat; 1977; (16 Pt 2):322-5. PubMed ID: 75005
    [No Abstract]   [Full Text] [Related]  

  • 16. [The elimination of hydroxyethyl starch 200/0.5, dextran 40 and oxypolygelatine (author's transl)].
    Köhler H; Zschiedrich H; Linfante A; Appel F; Pitz H; Clasen R
    Klin Wochenschr; 1982 Mar; 60(6):293-301. PubMed ID: 6176754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Low-molecular-weight hydroxyethyl starch or low-molecular-weight dextran in acute inner ear disorders? A randomized comparative study].
    Pilgramm M; Vestner HJ; Schumann K
    Laryngol Rhinol Otol (Stuttg); 1986 Jul; 65(7):377-80. PubMed ID: 2427904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hydroxyethyl starch: an agent for hypovolemic shock treatment.
    Mishler JM; Borberg H; Emerson PM; Gross R
    J Surg Res; 1977 Oct; 23(4):239-45. PubMed ID: 70572
    [No Abstract]   [Full Text] [Related]  

  • 19. Hydroxyethyl starch.
    Thompson WL
    Prog Clin Biol Res; 1978; 19():283-92. PubMed ID: 78499
    [No Abstract]   [Full Text] [Related]  

  • 20. [The effect of 6% hydroxyethyl starch 450/0.7, 10% dextran 40 and 3.5% gelatin on plasma volume in patients with terminal renal failure (author's transl)].
    Köhler H; Kirch W; Klein H; Distler A
    Anaesthesist; 1978 Sep; 27(9):421-6. PubMed ID: 82409
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.